Scottsdale Healthcare
Research Institute 

Scottsdale Healthcare is one of the southwest’s leading health systems, recognized for its medical innovations and superior personalized patient care. That same commitment to personalized care holds true for patients seen in clinical trials at the Scottsdale Healthcare Research Institute. 

Physicians and scientists at the Scottsdale Healthcare Research Institute collaborate with leading research universities and benefit in their unique personalized medicine approach by a strategic alliance with the Translational Genomics Research Institute (TGen), a world leader in developing smarter treatments for complex diseases. Scottsdale Healthcare is a primary clinical research site for TGen, providing patients with access to cutting edge technologies.

Through this alliance, patients with cancer have the opportunity to participate in clinical trials of revolutionary cancer treatments. 

In the past, these clinical trials were considered a last resort. Today, patients with cancer may have the option to receive their first treatment in a clinical trial. Evidence shows that patients who participate in clinical trials often benefit more than those who do not. 

Scottsdale Healthcare Research Institute’s cancer program is led by world-renowned cancer physician and researcher Daniel D. Von Hoff, MD, and is located in the Debi & Jerry Bisgrove Research Pavilion at Scottsdale Healthcare. Dr. Von Hoff is Chief Scientific Officer for Scottsdale Healthcare Research Institute, and is Physician-in-Chief at TGen.

For additional information about clinical trials available through Scottsdale Healthcare Research Institute, contact the Cancer Clinical Trials Coordinator at 480-323-1339 (toll free: 1-877-273-3713),
or e-mail clinicaltrials@shc.org.